Text size :

Drugs, Cicchetti (Cattolica): “Aifa could align therapies and tests for better access to care”

ADNKRONOS

November 12, 2026

Rome, Nov 12. (Adnkronos Health) – “The issue of alignment between drug availability and the availability of the related test could also be resolved through a role entrusted to the Italian Medicines Agency (Aifa). This would certainly be the most effective solution from a timing perspective and would ensure consistency and an immediate impact on the usability of therapy by citizens.” This was stated by Americo Cicchetti, full professor at the Catholic University of the Sacred Heart of Rome, speaking at the event ‘Essential Levels of Assistance and Next Generation Sequencing, The Challenge of Innovation between Update and Access’, which was held in Rome.

“From a technical point of view, it is a feasible solution, but it requires a realignment of competencies between the National Commission for the updating of LEAs, which reports to the General Directorate for Health Planning of the Ministry of Health, and Aifa. In many countries – he specified – this alignment already exists and leads to greater timeliness in access to innovation.”

“The risk, in our system, is that when a drug is introduced without the related test, it is necessary to identify additional resources, through ad hoc committees or by resorting to the resources of the Regions. This possibility, however, is reserved only for Regions that are not subject to a recovery plan. This creates further inequality in the system, precisely in terms of accessibility to innovation,” concluded Cicchetti.

Jiji Press

Related

Page TOP